Understanding how long-acting Telacebec works in the body
Pharmacokinetics of Long-Acting Preparations of Telacebec
This study is looking at how a new long-lasting HIV treatment called Telacebec works in the body using animal models, so we can learn more about its safety and effectiveness for people living with HIV in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Southern Research Institute NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11164319 on NIH RePORTER |
What this research studies
This research investigates the pharmacokinetics of long-acting preparations of Telacebec, a potential treatment for HIV. By studying how the drug is absorbed, distributed, metabolized, and excreted in animal models, researchers aim to gather essential data that could inform future clinical trials. The findings will help in understanding the drug's effectiveness and safety profile, ultimately guiding its development for human use. This research is crucial for advancing new therapies for patients living with HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who may benefit from new therapeutic options.
Not a fit: Patients who are not living with HIV or those who have already exhausted all treatment options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective long-acting treatments for HIV, improving patient adherence and outcomes.
How similar studies have performed: Previous research on pharmacokinetics of long-acting HIV treatments has shown promise, indicating that this approach could yield valuable insights.
Where this research is happening
Birmingham, United States
- Southern Research Institute — Birmingham, United States (Active)
Researchers
- Principal investigator: Bronner, Raymond — Southern Research Institute
- Study coordinator: Bronner, Raymond
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.